Canada Life’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Canada Life’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,139	Closed	-$22K	–	2806
2019 Q1	$22K	Hold	4,139	–	–	﹤0.01%	2367
2018 Q4	$20K	Hold	4,139	–	–	﹤0.01%	2543
2018 Q3	$40K	Hold	4,139	–	–	﹤0.01%	2437
2018 Q2	$42K	Hold	4,139	–	–	﹤0.01%	2443
2018 Q1	$54K	Hold	4,139	–	–	﹤0.01%	2351
2017 Q4	$74K	Hold	4,139	–	–	﹤0.01%	2261
2017 Q3	$104K	Buy	+4,139	New	+$96.3K	﹤0.01%	2138
2015 Q3	–	Sell	-1,970	Closed	-$52K	–	2607
2015 Q2	$52K	Buy	+1,970	New	+$55.9K	﹤0.01%	2200

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Canada Life's PRTK Position: Q2 2019 in Review

Canada Life sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2019, closing a stake of 4,139 shares — an estimated $22K sold.

Canada Life first reported a position in PRTK in Q2 2015 and held it in 8 quarters. The position peaked at $104K in Q3 2017. 89 funds tracked by Wall St. Rank hold PRTK as of Q2 2019.

Canada Life reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Canada Life sold 4,139 Paratek Pharmaceuticals, Inc. shares in Q2 2019, an estimated $22K.
Canada Life first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and held it in 8 quarters.
Canada Life's Paratek Pharmaceuticals, Inc. position peaked at $104K in Q3 2017.
89 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2019.

Based on Canada Life's 13F filing for Q2 2019, filed 31 Jul 2019.